Premium
Morbidity and mortality: Profile of patients on renal replacement therapy in the private sector
Author(s) -
Samaai R.,,
Uys H.
Publication year - 2005
Publication title -
hemodialysis international
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.658
H-Index - 47
eISSN - 1542-4758
pISSN - 1492-7535
DOI - 10.1111/j.1492-7535.2005.1121az.x
Subject(s) - medicine , renal replacement therapy , dialysis , hemodialysis , population , peritoneal dialysis , intensive care medicine , referral , mortality rate , diabetes mellitus , checklist , emergency medicine , family medicine , environmental health , psychology , cognitive psychology , endocrinology
The aim of renal replacement therapy (RRT) is to achieve a reduction in morbid events and improve quality of life (QOL). Mortality means the condition of being subject to death. Morbidity is anything that is abnormal, atypical, exceptional, and/or aberrant. Morbidity usually occurs as a result of a treatment (side effects), when treatment is inappropriate or inadequate. Predictors that may be risk factors for mortality and morbidity in dialysis patients can be divided into patient‐related and treatment‐related categories (Khan, 2000:11). Purpose of the study: The purpose of this retrospective study was to determine the morbidity and mortality profile of patients receiving RRT in the private sector. Research design and method: This study was contextual and descriptive in nature, based on case analysis of patients receiving RRT in private dialysis facilities. A checklist was used that made provisions to record all patient‐ and treatment‐ related factors that might influence mortality and morbidity profiles of the target population. The target population included all hemodialysis and peritoneal dialysis patients receiving treatment in private dialysis facilities of a specific company. Results: The results indicated the following factors have an influence on patient morbidity and mortality:– Patient related: Age, comorbid situations such as peripheral vascular, cerebrovascular, and cardiovascular disease and also diabetes mellitus. – Treatment related: Referral pattern, nutritional status, dialysis adequacy, anaemia, and blood pressure.